Randomized controlled trial to evaluate the efficacy and safety of silicon-covered metallic mesh stent compared to conventional polymeric stent in malignant ureteral obstruction patients
- Conditions
- Diseases of The genitoruinary system
- Registration Number
- KCT0004254
- Lead Sponsor
- S&G Biotech
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 76
1) Patients under the age of 20 and under 80 who understood the purpose of the clinical trial and signed a written consent form upon voluntary consent.
2) Patients with expected life expectancy of more than 3 months
3) Patients who have not previously undergone metal ureter stent insertion
4) Patients diagnosed with urethral stenosis due to malignant tumors
1) If diagnosed with urinary epithelial cancer
2) In case of bladder erosion of a malignant tumor
3) In case of past history of Kidney transmission
4) Patients with bladder function including reduction of bladder flow rate
5) Patients with ECOG performance status greater than 3
6) A woman who is likely to become pregnant, a woman who breast-feeds a baby.
7) If the researcher believes that the research is not suitable for carrying out the research
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method primary patency rate
- Secondary Outcome Measures
Name Time Method Technical success rate;Final patency rate;Primary patency rate;Adverse event;discomfort caused by stent;Patient survival rate for 6 months after treatment